BioSpace News Archive

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it will present new research data for patritumab deruxtecan (U3-1402) and ENHERTU® (fam-trastuzumab deruxtecan-nxki), two of its lead DXd antibody drug conjugates (ADC), at the 2020 European Society of Medical Oncology (ESMO) Virtual Scientific Program to be held September 19-21, 2020 (#ESMO20).

Collaboration will fast track the development and scale-up of Evonetix’s desktop DNA writer towards commercialisation and first product Technology will help facilitate the rapidly growing multibillion-dollar synthetic biology industry CAMBRIDGE, England--( BUSINESS WIRE )-- EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced a colla

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, ES Cell International Pte Ltd. (ESI), a subsidiary of Lineage, and AgeX Therapeutics, Inc.

Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update regarding the Company’s Wand® dental business, as well as the commercial roll-out of its CompuFlo® Epidural System and CathCheck™ technology.

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that management will present a corporate overview at H.C. Wainwright’s 22 nd Annual Global Investment Conference. Event details follow: Date: Tuesday, September 15 th Time: 2:30 p.m. Eastern Time Webcast: https://www.CassavaSciences.com/company-presentations Cassava Sciences’ virtual public

Repare Therapeutics Inc. announced that Lloyd M. Segal, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15 at 10:15 a.m.

Evogene Ltd., a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference.

Kraton Corporation (NYSE: KRA), a leading global producer of specialty polymers and high-value biobased products derived from pine wood pulping co-products, is seeking regulatory ap

Heat Biologics, Inc. today announced that Jeff Wolf, CEO of Heat Biologics, will participate on a virtual panel, entitled, New Approaches to COVID-19:

Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced data presentations on abaloparatide-SC at the upcoming American Society for Bone and Mineral Research (ASBMR) 2020 Annual Virtual Meeting which will take place between September 11-15. “We are excited that data from our histomorphometry study, showing that treatment with abaloparatide results in significant increase in bone formation in postmenopausal women with